Shigeki Yagyu

11PUBLICATIONS
43CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 23, 2026
Alectinib boosts anti-tumor efficacy of disialoganglioside 2 chimeric antigen receptor T cells in ALK-mutated neuroblastoma by suppressing programmed death-ligand 1.

Yuya Sugitatsu, Akimasa Tomida, Masaya Suematsu

|May 19, 2025
A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the SALL4 Promoter Inhibits the Growth of Rhabdoid Tumors.

Satoru Oya, Hideki Yoshida, Akimasa Tomida

|Mar 03, 2025
Feasibility of Intratumoral Administration With EPHB4-CAR-T Cells for the Treatment of Oral Squamous Cell Carcinoma.

Yusuke Ito, Toshihiro Suzuki, Manami Shimomura

|Mar 01, 2023
piggyBac-transposon-mediated CAR-T cells for the treatment of hematological and solid malignancies.

Shigeki Yagyu, Yozo Nakazawa

|Aug 31, 2021
CD146 is a potential immunotarget for neuroblastoma.

Satoshi Obu, Katsutsugu Umeda, Hiroo Ueno

|Aug 12, 2021
Inhibition of MEK pathway enhances the antitumor efficacy of chimeric antigen receptor T cells against neuroblastoma.

Akimasa Tomida, Shigeki Yagyu, Kayoko Nakamura

Pageof 2

Frequent Collaborators

5 joint publications

Tomoko Iehara

4 joint publications

Yozo Nakazawa

2 joint publications

Ken Kikuchi

2 joint publications

Shoji Saito